Investor Relations

REVA Medical, Inc. ("REVA" or the "Company") is a pre-revenue medical device company that is working to commercialize its proprietary bioresorbable scaffolds, as an alternative to metal stents, to treat coronary artery disease. Scaffolds provide restoration of blood flow, support the artery through the healing process, then disappear (or “resorb”) from the body over a period of time. This resorption allows the return of natural movement and function of the artery, a result not attainable with permanent metal stents...more »

 

View all »   RSSRecent Releases

Aug 10, 2016
REVA to Hold Briefing Call on Q2 2016 Financial Results

Aug 10, 2016
Notice of Briefing Call